Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • A declining trend of the daily reported new cases of Chandipura virus
    1 August 2024

    A declining trend of the daily reported new cases of Chandipura virus

    Since early June 2024, Acute Encephalitis Syndrome cases have been reported from Gujarat in children under 15 years of age. As on 31st July 2024, 148 AES cases 140 from 24 districts of Gujarat, 4 from Madhya Pradesh, 3 from Rajasthan & 1 from Maharashtra have been reported, out of which 59 cases have died. Chandipura virus has been confirmed in 51 cases.
  • 1 August 2024
    Lupin receives approval from USFDA for Emtricitabine and Tenofovir Alafenamide Tablets
    Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific APAC, Latin America LATAM, Europe, and Middle East regions.
  • 31 July 2024
    Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India, says GlobalData
    Zydus Life Sciences is engaged in a legal battle with Roche over its biosimilar, Sigrima, which is based on Roches Perjeta Pertuzumab, targeting the human epidermal growth factor receptor 2-positive breast cancer market in India.
  • 31 July 2024
    Action is taken against companies found selling formulations at prices higher than the permissible price
    As per the provisions of Drugs Order, 2013 , formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule –I are defined under Para of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013.
  • 31 July 2024
    Government of India schemes to encourage startups in pharmaceutical sector
    Startup India Initiative, launched on January 16, 2016, which aims to foster innovation and encourage investments across various industries, including the pharmaceutical sector. The initiative includes three flagship schemes viz., Fund of Funds for Startups; Startup India Seed Fund Scheme; and Credit Guarantee Scheme for Startups
  • 31 July 2024
    The virus that causes COVID-19 is widespread in wildlife : Scientists find

    SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to Virginia Tech research published today in Nature Communications. The virus was detected in six common backyard species and antibodies indicating prior exposure to the virus were found in five species with rates of exposure ranging from 40 to 60 percent depending on the species.

  • 31 July 2024
    Improving the Design of mRNA-loaded Nanocarriers for Targeted Therapies

    Substituting amines with phosphonium-based cations could greatly improve the performance of mRNA-loaded polymeric micelles, report scientists from Tokyo Tech. By adopting this innovative strategy, they managed to enhance the stability and mRNA-delivery capabilities of micelle nanocarriers into tumor tissue in vivo. Their results hint at the importance of exploring other cations besides amines in mRNA drug delivery and could pave the way to effective treatment for challenging diseases.

  • 29 July 2024
    Another Indian discovered medicine, deuruxolitinib gets FDA approval against baldness
    Indian Pharma giant, Sun Pharma gets the U.S. Food and Drug Administration, FDA approval for LEQSELVI deuruxolitinib 8 mg tablets for the treatment of adults with severe alopecia areata.
  • 25 July 2024
    Large genetic study on severe COVID-19 - Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene
    Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn UKB and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals.
  • 25 July 2024
    Fighting leukaemia by targeting its stem cells
    Acute myeloid leukaemia is one of the deadliest cancers. Leukaemic stem cells responsible for the disease are highly resistant to treatment. A team from the University of Geneva UNIGE, University Hospital of Geneva HUG, and Inserm has made a breakthrough by identifying some of the genetic and energetic characteristics of these stem cells, notably a specific iron utilisation process.
Subscribe to Pharma News